Biolife solutions to report fourth quarter and full year 2021 financial results and provide business update on february 28, 2022

Bothell, wash., feb. 21, 2022 /prnewswire/ --  biolife solutions, inc. (nasdaq: blfs), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("cgt") and broader biopharma markets, today announced the company's fourth quarter and full year 2021 financial results will be released after market close on monday, february 28 th.
BLFS Ratings Summary
BLFS Quant Ranking